Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Aryl Iodine Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.